| |
Term
|
Preterm
|
Total
|
P value*
|
|---|
|
N
|
Row%
|
N
|
Row%
|
N
|
Col%
|
|---|
|
Tubal factor
| | | | | | | |
|
No
|
341
|
82.8%
|
71
|
17.2%
|
412
|
84.1%
|
0.044
|
|
Yes
|
57
|
73.1%
|
21
|
26.9%
|
78
|
15.9%
| |
|
Endometriosis
| | | | | | | |
|
No
|
299
|
83.3%
|
60
|
16.7%
|
359
|
73.3%
|
0.053
|
|
Yes
|
99
|
75.6%
|
32
|
24.4%
|
131
|
26.7%
| |
|
Ovulation dysfunction
| | | | | | | |
|
No
|
190
|
84.1%
|
36
|
15.9%
|
226
|
46.1%
|
0.135
|
|
Yes
|
208
|
78.8%
|
56
|
21.2%
|
264
|
53.9%
| |
|
Uterine factor
| | | | | | | |
|
No
|
347
|
81.6%
|
78
|
18.4%
|
425
|
86.7%
|
0.540
|
|
Yes
|
51
|
78.5%
|
14
|
21.5%
|
65
|
13.3%
| |
|
Male factor
| | | | | | | |
|
No
|
243
|
82.4%
|
52
|
17.6%
|
295
|
60.2%
|
0.423
|
|
Yes
|
155
|
79.5%
|
40
|
20.5%
|
195
|
39.8%
| |
|
Unexplained infertility
| | | | | | | |
|
No
|
235
|
81.9%
|
52
|
18.1%
|
287
|
59.5%
|
0.604
|
|
Yes
|
156
|
80.0%
|
39
|
20.0%
|
195
|
40.5%
| |
|
Multiple female factors
| | | | | | | |
|
No
|
294
|
83.5%
|
58
|
16.5%
|
352
|
71.8%
|
0.037
|
|
Yes
|
104
|
75.4%
|
34
|
24.6%
|
138
|
28.2%
| |
|
Multiple female and male factors
| | | | | | | |
|
No
|
299
|
83.1%
|
61
|
16.9%
|
360
|
73.5%
|
0.084
|
|
Yes
|
99
|
76.2%
|
31
|
23.8%
|
130
|
26.5%
| |
|
Total
|
398
|
81.2%
|
92
|
18.8%
|
490
|
100.0%
| |
- *χ2 comparing to women who were not told or suspect diagnosis
- ∙ Diagnostic categories—SART CORS classification
- – Tubal factor—pelvic adhesion or scarring, blocked or damaged fallopian tubes
- – Endometriosis
- – Ovulation dysfunction—low progesterone, low estrogen, not ovulating, abnormal ovulation, lutenized unruptured follicule (LUF), Luteal Phase Defect (LUD), PCOS
- – Uterine factor—hostile or limited cervical mucus, fibroids in the uterus, polyps in the uterus,
- – Male factor
- – Unknown infertility—unexplained subfertility
- – Multiple female factors—more than one of the following diagnosis Tubal, Endometriosis, Ovulation dysfunction, or Uterine
- – Female and male factor—male factor plus at least one female factor
